R&D for Health (@RnDforHealth) header
R&D for Health (@RnDforHealth) profile picture

R&D for Health

@RnDforHealth

Our current Research & Development system is broken - let's fix it! @uaem #RnDforHealth #RnDAgreement

uaem.wufoo.com/forms/make-medicines-for-people-not-for-profit/
Joined November 2015
  • Tweets3.1K
  • Following1.5K
  • Followers967
674Media
Photo by R&D for Health (@RnDforHealth)Photo by R&D for Health (@RnDforHealth)Photo by R&D for Health (@RnDforHealth)Photo by R&D for Health (@RnDforHealth)Photo by R&D for Health (@RnDforHealth)Photo by R&D for Health (@RnDforHealth)Photo by R&D for Health (@RnDforHealth)Photo by R&D for Health (@RnDforHealth)Photo by R&D for Health (@RnDforHealth)Photo by R&D for Health (@RnDforHealth)
See what's wrong w current #RnD system and why we need #RnDAgreement: vimeo.com/144622081 Join in asking @WHO: bit.ly/1GHrhA3
How to fix the Research and Development system

How to fix the Research and Development system

#askyourminister to sign the treaty! sign our letter to the WHO member states and ask them to make medicines for people, not for profit. https://uaem.wufoo.com/forms/zmewncm1cznjbi/

vimeo.com
1
39
1
37
R&D for Health retweeted
Anthony So (@Anthony_So888) profile picture
Anthony So@Anthony_So88822 Jan 2021
Just 1 in 5 countries have identified funding for their National Action Plans for Antimicrobial Resistance. To stop #AMR from becoming the next pandemic, we need to do more to support @WHO Global Action Plan on AMR. It's time for the 5-year review #EB148 ignitetheidea.org/whoeb-amrb…
Image from Anthony So (@Anthony_So888)
1
25
7
55
R&D for Health retweeted
Thilo von Groote (@thilo_vg) profile picture
Thilo von Groote@thilo_vg30 Oct 2019
Replying to @Karl_Lauterbach
Richtig! Politik muss exzessive #Medikamentenpreise begrenzen, #AMNOG stärken und sicherstellen, dass Ergebnisse öffentlicher Forschung der Öffentlichkeit zugänglich werden. Sozial-gerechte #Technologietransfer-Richtlinien an Universitäten, wie bsw. an der @WWU_Muenster helfen! – at Berlin, Germany
2
1
3
After 15 years, we’ve proven that not-for-profit research and development can deliver effective and affordable new 💊treatments. But what lessons have we learnt in delivering public-interest R&D? Read our new policy paper ➡️ bit.ly/2NtJIy2 #DNDi15Years #WHS2019
Cover image of our report "15 years of needs-driven innovation for access"

ALT Cover image of our report "15 years of needs-driven innovation for access"

1
42
7
59
R&D for Health retweeted
Els Torreele (@ElsTorreele) profile picture
Els Torreele@ElsTorreele29 Oct 2019
Replying to @MSF_access @CEPIvaccines
@doctorsoumya @GKangInd @DavidAReddy @JNkengasong @CWattsLSHTM @DFID_UK @BMBF_Bund @Gateshealth @wellcometrust @noradno @JeremyFarrar @trevormundel @DrRHatchett
2
2
R&D for Health retweeted
MSF Access (@MSF_access) profile picture
MSF Access@MSF_access29 Oct 2019
Good news from @CEPIvaccines: They established a Board subcommittee on Equitable Access!
Image from MSF Access (@MSF_access)
1
11
1
21
R&D for Health retweeted
Markus (@Markus_W_Erner) profile picture
Markus@Markus_W_Erner23 Oct 2019
"Medizinische Fakultäten ignorieren Interessenkonflikte" - Wieso werden wir als Medizinstudenten dazu nicht aufgeklärt? Wieso wurden die Fragen der Studie von @uaem und @bvmd_like nicht von der @WWU_Muenster beantwortet? Sicher spannend für @WN_Redaktion sueddeutsche.de/wissen/pharm…
Big Pharma: Unis ignorieren Beeinflussung

Big Pharma: Unis ignorieren Beeinflussung

Arzneimittelhersteller fangen schon im Studium an, Mediziner zu beschenken. Fast keine deutsche Hochschule schützt ihre Studenten vor den Folgen.

sueddeutsche.de
2
6
R&D for Health retweeted
UAEM-Germany (@UAEMGermany) profile picture
UAEM-Germany@UAEMGermany21 Oct 2019
Die Drugs for Neglected Diseases initiative (@DNDi) hosted nächste Woche ein Symposium anlässlich d. 15-jährigen Bestehens zur Entwicklung neuer #Medikamente gegen #vernachlässigteKrankheiten. Wir gratulieren herzlich! Infos und Anmeldung zur Verantsaltung:web.cvent.com/event/28eeb2f4…
Thilo von Groote (@thilo_vg) profile pictureThilo von Groote@thilo_vg21 Oct 2019
Really looking forward to attend the @DNDi reception in Berlin on Tuesday next week! It will be an inspirational event with a lot to celebrate in the 'Drugs for Neglected Diseases initiative' (DNDi)'s 15 year history of alternative R&D in #drugdevelopment! web.cvent.com/event/28eeb2f4…
Image from Thilo von Groote (@thilo_vg)
1
3
R&D for Health retweeted
Thilo von Groote (@thilo_vg) profile picture
Thilo von Groote@thilo_vg21 Oct 2019
Really looking forward to attend the @DNDi reception in Berlin on Tuesday next week! It will be an inspirational event with a lot to celebrate in the 'Drugs for Neglected Diseases initiative' (DNDi)'s 15 year history of alternative R&D in #drugdevelopment! web.cvent.com/event/28eeb2f4…
Image from Thilo von Groote (@thilo_vg)
1
2
1
10
R&D for Health retweeted
UAEM-Germany (@UAEMGermany) profile picture
UAEM-Germany@UAEMGermany18 Oct 2019
Die Beeinflussung durch Big-Pharma beginnt nicht erst im Sprechzimmer, sondern bereits im Hörsaal! Aber mehr Werbung führt nicht zu besserer Anwendung von Medikamenten. Nur 2/38 Medizin-Unis gehen offiziell dagegen vor. @KaiGehring @Karl_Lauterbach @KirstenKappert @bvmd_like
tagesschau (@tagesschau) profile picturetagesschau
@tagesschau17 Oct 2019
Studie weist auf Interessenkonflikte an medizinischen Unis hin tagesschau.de/investigativ/n… #Investigativ #Interessenkonflikt #Mediziner #Arzt
10
1
14
R&D for Health retweeted
UAEM-Germany (@UAEMGermany) profile picture
UAEM-Germany@UAEMGermany17 Oct 2019
#Pharmafirmen geben viel Geld für Geschenke und teure Kongressreisen für Medizinstudierende aus. Eine Studie von @UAEMGermany und @bvmd_like zeigt, dass Universitäten klarer über #Interessenskonflikte aufklären müssen! #Medizin #Universität sz.de/1.4644884
Big Pharma: Unis ignorieren Beeinflussung

Big Pharma: Unis ignorieren Beeinflussung

Arzneimittelhersteller fangen schon im Studium an, Mediziner zu beschenken. Fast keine deutsche Hochschule schützt ihre Studenten vor den Folgen.

sueddeutsche.de
1
3
1
8
R&D for Health retweeted
MSF Access (@MSF_access) profile picture
MSF Access@MSF_access2 Oct 2019
1- We wrote a letter to pharma corporation @abbvie because we urgently need #hepatitisC drug glecaprevir/pibrentasvir (G/P). There are people around the world, including in our care, who need this drug, but can’t access it.
Image from MSF Access (@MSF_access)
2
24
1
30
R&D for Health retweeted
MSF Access (@MSF_access) profile picture
MSF Access@MSF_access2 Oct 2019
5- Time’s up, @abbvie ⏲ Answer our requests now and make G/P available to everyone who needs it. Allow @MSF to buy the lifesaving drug and publish its price for everyone to see. Read our full letter here 👉 bit.ly/2ospVq2
Open letter to AbbVie on access to critical hepatitis C treatment – glecaprevir/pibrentasvir (G/P)

Open letter to AbbVie on access to critical hepatitis C treatment – glecaprevir/pibrentasvir (G/P)

Médecins Sans Frontières (MSF) Access Campaign wrote an open letter to pharmaceutical corporation AbbVie to express our urgent need for glecaprevir/pibrentasvir (G/P) combination to treat people with...

msfaccess.org
13
18
R&D for Health retweeted
Ärzte ohne Grenzen (@msf_de) profile picture
Ärzte ohne Grenzen@msf_de19 Sep 2019
Deutschland muss sich @CEPIvaccines Verwaltungsrat für eine starke Zugangspolitik einsetzten! @AnjaKarliczek @BMBF_Bund : Menschenleben müssen wichtiger als die Interessen von Pharmakonzernen sein und #Impfstoffe für alle bezahlbar! #Germany4globalhealth msf.de/yI
9
13
R&D for Health retweeted
MSF Access (@MSF_access) profile picture
MSF Access@MSF_access13 Sep 2019
Replying to @MSF_access @CEPIvaccines @trevormundel @GKangInd @JNkengasong @DrRHatchett @JeremyFarrar
Dear members of the Board of @CEPIVaccines: At your upcoming Board meeting next week, we ask you to ensure that CEPI’s policy is revised in the interest of the people it aims to protect. ⚡ CEPI Money = Public Money
Image from MSF Access (@MSF_access)
1
6
1
5
R&D for Health retweeted
Thilo von Groote (@thilo_vg) profile picture
Thilo von Groote@thilo_vg13 Sep 2019
I think @MSF_access is 100% right in urging @CEPIvaccines to revise their #intellectualpolicy & #drugprices policy to ensure fair return on public investment and #accesstomedicines! All eyes on you,@DrRHatchett @JNkengasong @NadineGbossa @trevormundel @doctorsoumya &Co. #vaccines
MSF Access (@MSF_access) profile pictureMSF Access@MSF_access13 Sep 2019
Replying to @MSF_access @CEPIvaccines @trevormundel @GKangInd @JNkengasong @DrRHatchett @JeremyFarrar
Dear members of the Board of @CEPIVaccines: At your upcoming Board meeting next week, we ask you to ensure that CEPI’s policy is revised in the interest of the people it aims to protect. ⚡ CEPI Money = Public Money
Image from MSF Access (@MSF_access)
1
5
9
Time to make essential cancer drugs more affordable ft.com/content/06a76e44-a965… via @financialtimes
Time to make essential cancer drugs more affordable

Time to make essential cancer drugs more affordable

Governments can do more to pressure makers to bring down prices

ft.com
12
1
20
R&D for Health retweeted
Thilo von Groote (@thilo_vg) profile picture
Thilo von Groote@thilo_vg22 Jul 2019
It is "Time to make essential cancer drugs more affordable" writes @jamie_love in @financialtimes. As new #medicines for #CancerTreatment provide effective treatment for #cancer, still too many patients do not have access to these essential medicines. @WHO ft.com/content/06a76e44-a965…
2
3
R&D for Health retweeted
Thilo von Groote (@thilo_vg) profile picture
Thilo von Groote@thilo_vg13 Jul 2019
Replying to @thilo_vg @cochranecollab
Cochrane had issued the statement after a recently released joint letter from the Euopean Medicines Agency @EMA_News, the @EU_Commission and the Heads of Medicines Agencies: ema.europa.eu/en/news/call-a…
2
3
R&D for Health retweeted
Thilo von Groote (@thilo_vg) profile picture
Thilo von Groote@thilo_vg13 Jul 2019
Great to see @cochranecollab strongly supporting the #AllTrials campaign for transparency of all #clinicaltrials results! 👏@KarlaWeiser cochrane.org/news/cochrane-s…
Image from Thilo von Groote (@thilo_vg)
1
4
4
R&D for Health retweeted
Thilo von Groote (@thilo_vg) profile picture
Thilo von Groote@thilo_vg13 Jul 2019
Replying to @thilo_vg @jensspahn @Karl_Lauterbach @KaiGehring @MariaKlSchmeink
Vorschläge u.a.: - Regulatoren sollten weniger tolerant sein für schlechte Studien & mangelnde Evidenz - wiss. Fachgesellschaften sollten relevante Outcomes definieren zur Bewertung der Studien - pro-aktivere policy makers, Forschung an Bedürfnissen der Gesellschaft ausrichten
1
2
2
Load more